Abstract
Abstract This chapter discusses how model-based design of experiments (MBDoE) techniques may be instrumental to the model development and identification effort in pharmacokinetics and pharmacodynamics. After introducing the formal MBDoE framework, two case studies will be discussed to show how the methodology can be implemented, and to illustrate the benefits in terms of parametric estimation. The first case study considers a model describing in vitro bacterial growth and killing, whereas the second one focuses on a physiological description of the von Willebrand disease. The effectiveness of the MBDoE approach will be demonstrated through a comparison with standard pharmacological experiments and clinical tests.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
